Deals
Peltz’s Trian Building Stake in 3M Spinoff Solventum
- Activist now one of the biggest shareholders in Solventum
- Trian wants Solventum to consider asset sales to unlock value
This article is for subscribers only.
Activist investor Nelson Peltz’s Trian Fund Management has amassed a stake in 3M Co.’s health-care spinoff Solventum Corp.
Trian is now one of the largest shareholders in Solventum, which became a standalone public company this year and has a market value of about $9.4 billion, a representative for Trian said in an emailed statement, confirming a report by Bloomberg News. The exact size of Trian’s holding couldn’t immediately be learned.